EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Advances in the natural α‐glucosidase inhibitors

Didem Şöhretoğlu, Gülin Renda, Randolph Arroo, Jianbo Xiao, Suat Sari

eFood · 2023-10 · 4 (5)

DOI: 10.1002/efd2.112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eFood, online erschienen am 12.09.2023. Verfasst von Didem Şöhretoğlu und 4 weiteren Autor:innen. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α‐Glucosidase (AG) inhibitors, one of the classes of oral antidiabetics used to treat type 2 diabetes mellitus, delay digestion and absorption of glucose, which in turn, has a lowering effect on postprandial blood glucose and insulin levels. Natural products are a great source for the development of new AG inhibitory drug candidates. We aim to summarize advances in natural AG inhibitors according to their secondary metabolite groups in the last decade. Their mechanisms of action and structure–activity relationships will especially be discussed.

Zitieren

APA

Şöhretoğlu, D., Renda, G., Arroo, R., Xiao, J., & Sari, S. (2023). Advances in the natural α‐glucosidase inhibitors. eFood, 4(5). https://doi.org/10.1002/efd2.112

Vancouver

Şöhretoğlu D, Renda G, Arroo R, Xiao J, Sari S. Advances in the natural α‐glucosidase inhibitors. eFood. 2023;4(5). doi:10.1002/efd2.112

BibTeX
@article{hretolu2023,
  author = {Şöhretoğlu, Didem and Renda, Gülin and Arroo, Randolph and Xiao, Jianbo and Sari, Suat},
  title = {Advances in the natural α‐glucosidase inhibitors},
  journal = {eFood},
  year = {2023},
  volume = {4},
  number = {5},
  doi = {10.1002/efd2.112}
}
Kostenlos starten →